Introduction to the 2025 CBIIC

In the context of accelerating iterations of emerging technologies globally, complex evolution of economic landscapes, and profound restructuring of industrial chains, China’s pharmaceutical industry is embracing a strategic window of opportunity for a paradigm shift in innovation. To promote the integration of social capital and pharmaceutical innovation and enhance innovation capabilities, the 2025 China BioMed Innovation and Investment Conference (2025 CBIIC) is scheduled to be held in Nanjing from October 26 to 27. Under the theme “A Decade of Innovation, Invest in the Future,” the 2025 CBIIC introduces a new format for project roadshows. It aims to establish a full-industry-chain dialogue platform encompassing government, industry, academia, research, application, and capital. With a focus on industrial policies, global pharmaceutical R&D trends, and investment dynamics, the event will explore new directions in innovation and development, foster strategic discussions on investment cooperation, and contribute Chinese insights to the reshaping of the global pharmaceutical landscape.